CAREVIEW MEDICAL GROUP LTD

Executive Summary

CAREVIEW MEDICAL GROUP LTD is a recently formed dormant company with no substantive financial activity or assets beyond the nominal share capital. The company presents a high risk profile due to absence of trading history and recent director turnover, limiting assessment of operational and financial stability. While compliance with filing requirements is up to date, further due diligence is needed to clarify future business intentions and management continuity.

CAREVIEW MEDICAL GROUP LTD - Analysis Report

Company Number: 14548246

Analysis Date: 2025-07-20 19:03 UTC

1. Risk Rating: HIGH

Justification: The company is newly incorporated (December 2022), has filed dormant accounts showing virtually no financial activity or assets (net assets £1), and no operating results are available. Control is concentrated in one individual who resigned as director shortly after incorporation, with a new director appointed recently. The company’s stated SIC code relates to real estate letting, but there is no evidence of operational activity or financial substance at this stage. These factors indicate very limited financial history or operational track record, resulting in a high risk profile from a solvency and liquidity perspective.

2. Key Concerns:

• Dormant status with minimal net assets (£1) and no trading history raises concerns about the company’s ability to meet financial obligations.
• Recent director turnover may indicate instability or restructuring; the main controlling shareholder resigned as director within one year.
• Lack of operational or financial data limits visibility on business sustainability or revenue generation potential.

3. Positive Indicators:

• Company is currently active and compliant with filing deadlines for accounts and confirmation statements, indicating governance awareness.
• Director and PSC details are clearly reported, with no disqualifications or adverse records noted.
• The company benefits from the dormant company exemption, reducing immediate compliance burden.

4. Due Diligence Notes:

• Investigate the business plan and intended activities to understand the timeline for commencement of trading and revenue generation.
• Confirm the reasons for director resignation and the background of the current director to assess management stability.
• Verify any off-balance sheet commitments or related party transactions not reflected in dormant accounts.
• Monitor subsequent filings for signs of financial activity or capital injection that would enhance solvency.